Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
668
datasets available to search
ShareScore release 0.9.0
Dataset results
668 results for “Everolimus”
A Study of Cabozantinib (XL184) vs Everolimus in Subjects With Metastatic Renal Cell Carcinoma
ClinicalTrials.gov study NCT01865747. IPD Sharing: Not stated. Countries: 26. Publications: 9.
Everolimus in Treating Patients With Newly Diagnosed Localized Prostate Cancer
ClinicalTrials.gov study NCT00526591. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Everolimus as Second-line Therapy in Metastatic Renal Cell Carcinoma
ClinicalTrials.gov study NCT01491672. IPD Sharing: Not stated. Countries: 6. Publications: 2.
Everolimus (RAD001) Therapy for Epilepsy in Patients With Tuberous Sclerosis Complex (TSC)
ClinicalTrials.gov study NCT01070316. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Everolimus (RAD001) in Primary Therapy of Waldenstrom's Macroglobulinemia
ClinicalTrials.gov study NCT00976248. IPD Sharing: Not stated. Countries: 1. Publications: 1.
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
ClinicalTrials.gov study NCT01674140. IPD Sharing: Not stated. Countries: 2. Publications: 2.
Efficacy and Safety Study of Everolimus Plus Reduced Cyclosporine Versus Mycophenolic Acid Plus Cyclosporine in Kidney Transplant Recipients
ClinicalTrials.gov study NCT00251004. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Everolimus in Treating Cutaneous T-cell Lymphoma
ClinicalTrials.gov study NCT01637090. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy and Safety of Everolimus (RAD001) Compared to Placebo in Patients With Advanced Neuroendocrine Tumors
ClinicalTrials.gov study NCT00510068. IPD Sharing: Not stated. Countries: 18. Publications: 5.
Conversion to Everolimus From Calcineurin Inhibitor With Mycophenolic Acid: Impact on Long Term Renal Function in Liver Transplantation.
ClinicalTrials.gov study NCT01936519. IPD Sharing: YES. Countries: 1. Publications: 29.
Study of Everolimus (RAD001) in Combination With Lenalidomide
ClinicalTrials.gov study NCT01218555. IPD Sharing: Not stated. Countries: 1. Publications: 1.
RAD001(Everolimus) in Treating Patients With Myelodysplastic Syndromes
ClinicalTrials.gov study NCT00809185. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Everolimus Therapy in People With Birt-Hogg-Dube Syndrome (BHD)-Associated Kidney Cancer or Sporadic Chromophobe Renal Cancer
ClinicalTrials.gov study NCT02504892. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Thin Strut Sirolimus-eluting Stent in All Comers Population vs Everolimus-eluting Stent
ClinicalTrials.gov study NCT02870140. IPD Sharing: UNDECIDED. Countries: 7. Publications: 3.
12 Month Athena Study: Everolimus vs. Standard Regimen in de Novo Kidney Transplant Patients
ClinicalTrials.gov study NCT01843348. IPD Sharing: Not stated. Countries: 2. Publications: 2.
Carboplatin, Paclitaxel, and Everolimus in Treating Patients With Previously Untreated Cancer of Unknown Primary
ClinicalTrials.gov study NCT00936702. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Trial to Assess Safety and Efficacy of Lenvatinib (18 mg vs. 14 mg) in Combination With Everolimus in Participants With Renal Cell Carcinoma
ClinicalTrials.gov study NCT03173560. IPD Sharing: NO. Countries: 16. Publications: 1.
24 Months Follow-up, Two Arm Study to Compare the Cardiovascular Profile in a Regimen With Everolimus + Mycophenolic Acid (MPA) Versus (vs.) a Regimen of CNI+MPA in Maintenance Renal Transplant Recipi
ClinicalTrials.gov study NCT01169701. IPD Sharing: Not stated. Countries: 1. Publications: 1.
First-line Everolimus +/- Paclitaxel for Cisplatin-ineligible Patients With Advanced Urothelial Carcinoma
ClinicalTrials.gov study NCT01215136. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Eribulin Mesylate and Everolimus in Treating Patients With Triple-Negative Metastatic Breast Cancer
ClinicalTrials.gov study NCT02120469. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.